Ayala Pharmaceuticals Inc. (ADXS) Annual Income Statement ()
ADXS Quarterly Financials ()
Frequently Asked Questions About Ayala Pharmaceuticals Inc. (ADXS) Stock
Ayala Pharmaceuticals Inc. 's (ADXS) last reported annual revenue was USD 13000.00.
Ayala Pharmaceuticals Inc. 's (ADXS) annual revenue growth rate based on the revenue reported in the past 5 years is : -70.74%
Ayala Pharmaceuticals Inc. 's(ADXS) is not profitable as of its last reported annual financials.
The net profit margin for Ayala Pharmaceuticals Inc. 's(ADXS) from its laster reported year is -369784.62%
The return on equity (ROE) for Ayala Pharmaceuticals Inc. 's(ADXS) from its last reported annual financials is : 0.00%
The return on assets (ROA) for Ayala Pharmaceuticals Inc. 's(ADXS) from its last reported annual financials is : -181.05%
The return on invested capital (ROIC) for Ayala Pharmaceuticals Inc. 's(ADXS) from its last reported annual financials is : 222.82%
The Debt to Equity ratio for Ayala Pharmaceuticals Inc. 's(ADXS) from its last reported annual financials is : -33.34%
The dividend yield for Ayala Pharmaceuticals Inc. 's(ADXS) from its laster reported year is 0.00%
Ayala Pharmaceuticals Inc. 's(ADXS) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ADXS !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
